U.S. Physical Therapy (NYSE:USPH) issued an update on its FY19 earnings guidance on Thursday morning. The company provided EPS guidance of $2.87-2.97 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.93.
NYSE USPH traded down $2.47 during mid-day trading on Friday, reaching $131.37. The stock had a trading volume of 81,968 shares, compared to its average volume of 83,548. U.S. Physical Therapy has a 1 year low of $98.69 and a 1 year high of $135.01. The firm has a market cap of $1.71 billion, a PE ratio of 49.57, a PEG ratio of 4.07 and a beta of 1.13. The business’s fifty day moving average price is $125.34. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.39.
U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.81 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.81. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.50%. The company had revenue of $126.40 million during the quarter, compared to analyst estimates of $124.86 million. During the same period in the previous year, the business earned $0.73 EPS. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. On average, research analysts expect that U.S. Physical Therapy will post 2.92 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Thursday, August 15th will be issued a $0.30 dividend. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.27. This represents a $1.20 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date is Wednesday, August 14th. U.S. Physical Therapy’s payout ratio is presently 40.75%.
A number of equities analysts recently weighed in on USPH shares. Barrington Research restated a hold rating on shares of U.S. Physical Therapy in a report on Friday, May 3rd. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a hold rating to a buy rating and set a $127.00 price objective for the company in a report on Friday, April 26th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has an average rating of Buy and an average price target of $113.54.
In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 19,860 shares of the business’s stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $119.36, for a total transaction of $2,370,489.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.50% of the stock is currently owned by insiders.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading: Hedge Funds Explained
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.